Fragile histidine triad (FHIT) is a suppressor gene related to cervical cancer through CpG island hypermethylation. Folate is a water-soluble B-vitamin and an important cofactor in one-carbon metabolism. It may play an essential role in cervical lesions through effects on DNA methylation. The purpose of this study was to observe effects of folate and FHIT methylation and HPV 16 on cervical cancer progression. In this study, DNA methylation of FHIT, serum folate level and HPV16 status were measured using methylation-specific polymerase chain reaction (MSP), radioimmunoassay (RIA) and polymerase chain reaction (PCR), respectively, in 310 women with a diagnosis of normal cervix (NC, n=109), cervical intraepithelial neoplasia (CIN, n=101) and squamous cell carcinoma of the cervix (SCC, n=101). There were significant differences in HPV16 status ( 
Introduction
Cervical cancer is one of the most common cancers in women globally and is responsible for the large percentage of women's death in developing countries. Epidemiological and laboratory data have shown that persistent infection with oncogenic human papillomavirus (HPV), particularly HPV-16 and HPV-18, is the main risk factor, but not solely responsible for the development of cervical cancer. Other cofactors including genetic and epigenetic factors, may facilitate the progression of cervical cancer as well.
Previous studies have reported that DNA methylation of genes is a frequent epigenetic factor in cervical cancer . Aberrant DNA methylation in the CpG islands at the promoter region is an important epigenetic mechanism underlying the inactivation of tumor suppressor genes (Abouzeid et al., 2011) . The fragile histidine triad (FHIT) gene is a candidate tumor suppressor gene located at chromosome 3p14.2 encompassing the FRA3B site, which is the most active fragile site in the human genome. The reduced FHIT expression was associated with the high CpG island methylation (Al-Temaimi et al., 2013) . The promoter methylation status of the FHIT gene was observed in a number of cancers, such as breast cancer (Jeong et al., 2013) , lung cancer (Tan et al., 2013) , non-small cell lung carcinomas (Haroun et al., 2014; Li et al., 2014) , bladder cancer (Han et al., 2011) and Nasopharyngeal Carcinoma (Chen et al., 2013) , and others as well. In cervical cancer tissues, the methylation rate of the FHIT gene promoter was also significantly higher than in cervical intraepithelial neoplasia and normal cervical tissues (66.0 vs. 59.1 vs. 25.0 %, P=0.0033) (Banzai et al., 2014) . Folate is a water-soluble B-vitamin and an important cofactor in one-carbon metabolism in which folate participates in nucleotide synthesis and methylation reactions (Wang et al., 2011; Pathak et al., 2012) . The relationship between folate deficiency and cervical cancer has not been consistent. Some evidence has suggested that folate deficiency may increase the risk of cancers and may have other negative effects on human health (Tomaszewski et al., 2011) . However, in an India study, there was no statistically significant association between folate levels and cervical carcinogenesis. This was observed in 136 control subjects, 92 low-grade squamous intraepithelial lesions (LSIL) subjects, and 94 invasive cervical cancer cases (ICC) in Kerala, South India (Ragasudha et al., 2012) . The previous findings of our team indicated that the low level of serum folate was significantly associated with cervical carcinogenesis (Jin-Tao et al., 2014) , and the cell proliferation decreased and the apoptosis increased with the concentration of folate increasing in human cervical cancer cell lines (Ding et al., 2013) .
Above all, high FHIT methylation and low serum folate and HPV infection may be risk factors for cervical cancer independently. However, few studies reported how they work together in cervical cancer progression. Hence, the present study was conducted to study their interactions by examining serum folate and DNA methylation of tumour suppressor gene FHIT and HPV 16 in women ranging from normal cervix to cervical intraepithelial neoplasia to squamous cell carcinoma of the cervix.
Materials and Methods
In this study, after been approved by the institutional Review Board (IRB) of the appropriate hospitals where the participants came from and informed consent was obtained from the patients, the author obtained blood and tissues of participants.
Blood collection
Prior to surgery or other treatments, a 3 ml blood sample was drawn in the morning after an overnight fasting (12 hours) and centrifuged at 4000 rpm for 15 minutes at room temperature within 10 hours of collection. Plasma and serum were separated, and serum was drawn into an EP tube and stored at -80℃ until analysis. Blood folate (folic acid) levels were determined by radioimmunoassay (RIA) (Dongya Institute of Biological Medicine, Beijing, China).
Cervical tissues collection
Samples of squamous cell carcinoma of the cervix tissues were derived from patients who experienced primary surgery for cervical diseases at the Department of Gynaecology and Obstetrics in Tumor hospital of Shanxi Province (Taiyuan, China), and cervical intraepithelial neoplasia tissues and normal cervix underwent vaginoscope inspection from the Second Affiliated Hospital of Shanxi Medical University (Taiyuan, China) from June 2008 to August 2009. All of the selected cervical tissues met the criteria including no history of any other type of malignant tumor, without neoadjuvant therapy prior to surgery and without using vitamin B in the past three months. All the cervical tissues were put into the nitrogen canister immediately and then storaged in a refrigerator at -80℃.
Polymerase chain reaction (PCR)
Polymerase Chain Reaction (PCR) primers for HPV16 E2 and E6 were purchased from Integrated DNA Technologies (Shanghai, China). All primers are shown in Table 1 .
PCR was performed in 50µl reaction volumes containing 10×PCR buffer. DNA was amplified using the following protocol: 95ºC for 5 minutes followed by 30 cycles of 95ºC for 60 seconds, 55ºC for 60 seconds, 72ºC for 60 seconds, and finally of 72ºC for 10 minutes.
Methylation-specific polymerase chain reaction
Methylation-specific polymerase chain reaction (MSP) primers for FHIT (Gene ID: 2272) were purchased from Integrated DNA Technologies (Shanghai, China). All primers are also shown in Table 1 .
MSP was performed in 50µl reaction volumes containing 10×PCR buffer. DNA was amplified using the following protocol: 95ºC for 5 minutes followed by 40 cycles of 94ºC for 30 seconds, 56ºC for 30 seconds, 72ºC for 30 seconds, and finally of 72ºC for 7 minutes.
Statistical analysis
A comparison of categorical variables among histology groups was examined by χ 2 test; continuous variables were tested by ANOVA analysis and if a significant difference was detected, further Post-Hoc test was used.
Results

Demographic characteristics
In the present study, there were three groups of participants. Specifically, 100 women were aged 31-75 years (median±SD: 49.00±10.75 y) in squamous cell carcinoma of the cervix group (SCC), 101 women were aged 29-67 years (48.00±12.00 y) in cervical intraepithelial neoplasia group (CIN), and 109 women were aged 24-81 years (47.00±13.50 y) in normal cervix DOI:http://dx.doi.org/10.7314/APJCP.2014.15.21.9313 Folate Deficiency, FHIT Hypermethylation and HPV 16 Infection Promote Cervical Cancerization (NC) group (control group). There were no significant differences in age, nationality, birthplace, city of residence, and marital status among the SCC, CIN and NC groups. Table 3 shows a statistically significant difference in the proportion of CpG island methylation of tumor suppressor gene FHIT across the cervical histologic grades (χ 2 =71.31; P<0.001). The rate of CpG island methylation of FHIT in the SCC group was significantly higher than that in the NC group (χ 2 =42.67; P<0.001), but the significant difference was not observed between the CIN and NC groups (Fhisher χ 2 , P=1.000).
Detection of HPV16
Detection of CpG island methylation of FHIT
Serum folate levels
The level of serum folate among the three groups was significantly different which was tested by the ANOVA (Table 4) . Women with SCC had a significantly lower serum folate level than women with normal cervical histology (P<0.0167, Adjusted test α=α/3=0.0167), but there was no significant difference between SCC and CIN groups (P>0.0167) and between CIN and NC groups (P>0.0167). Table 5 shows the three factors for interactions between HPV infection and FHIT methylation and serum folate levels in SCC and CIN groups respectively. The odds ratios (OR) in different conditions were calculated compared with the "control status" of HPV 16 negative and FHIT unmethylation and serum folate level more than 3.19ng/ml. It was observed that women only with FHIT methylation (OR=11.47) or only with HPV 16 positive (OR=4.63) or with a serum folate level lower than 3.19ng/ ml (OR=1.68) were more likely to be SCC compared with the "control status" (OR=1), and women only with HPV 16 positive (OR=2.58) or with a serum folate level lower than 3.19ng/ml (OR=1.28) were more likely to be CIN compared with the "control status" , but women only with FHIT methylation (OR=0.53) in CIN group were lower than the control status. HPV 16 positive was associated with a 7.60-fold increased risk of SCC with folate deficiency and with a 1.84-fold increased risk of CIN. The patients with FHIT methylation and folate deficiency or with FHIT methylation and HPV 16 positive were all SCC or CIN, and the patients with HPV 16 positive, FHIT methylation and folate deficiency were all SCC.
Interactions between HPV infection and FHIT methylation and serum folate levels in SCC and CIN groups
Discussion
The key finding in this study is that the serum folate level, CpG island hypermethylation of FHIT and HPV 16 positive are significantly associated with the progression of cervical lesions. Serum folate levels significant differed between the SCC and NC groups, but no significant difference was observed between SCC and CIN groups. FHIT showed increased methylation with increasing severity of cervical neoplastic changes. Interaction analysis showed the odds ratios of HPV 16 infection and FHIT methylation and folate deficiency existed at the same time or when two of them existed were higher than one of them existed, the ORs of which were all higher than the control status of HPV 16 negative and FHIT unmethylation and serum folate level higher than 3.19ng/ ml in SCC and CIN.
Folate is important for normal cell division. Folate deficiency has many negative effects on health and can be one of the risk factors of cancers which has been widely documented. This study showed that folate level in SCC group was statistically lower than that in the NC group, but no significant difference was found between the SCC and CIN groups and between the CIN and NC groups. It implied that folate deficiency had more influence on SCC than CIN and NC. Previous studies reported that folate status was associated with the natural history of HR-HPV infection. An Indian study with 742 women found that women with higher serum folate levels (>6ng/ml) were at a lower risk of HR-HPV positivity compared to those with serum folate levels ≤6ng/ml . In a prospective study including 345 subjects, the results showed that women with higher folate status had a higher risk of becoming HR-HPV-positive (Piyathilake et al., 2004) . A research study in Turkey including 122 women also indicated that the means of serum folate level in HSIL or LSIL or ASCUS group were lower than that of the control group (P<0.05). Another report showed that in all cervical dysplasia groups, folate levels were lower in HPV-positive patients than in HPV-negative patients (P<0.05) (Abike et al., 2011) . A multicenter case control study that involved 927 Korean women (440 controls, 165 patients with CIN1, 167 with CIN2/3, and 155 with cervical cancer) reported that patients with cervical cancer had significantly lower median serum folate levels than controls and the linear trend test showed significant associations between higher serum folate levels and lower cancer risks (P for linear trend=0.0058) (Tong et al., 2011) . However, a recent study including 322 women (136 control subjects, 92 low-grade squamous intraepithelial lesions (LSIL), 94 invasive cervical cancer cases(ICC)) in South India did not find significant associations between folate levels and cervical carcinogenesis (Ragasudha et al., 2012) . FHIT is a suppressor gene related to cervical cancer through CpG island hypermethylation. In this study, the SCC group had a significantly higher rate of CpG island methylation than the NC group, although no statistical difference was observed between the CIN and NC groups. A positive correlation was observed between methylation rates and progression of cervical cancer. The results showed that the vital role of FHIT methylation in cervical carcinogenesis, which was supported by previous studies. A case-control study found that FHIT methylation was observed in 28.3% (17/60) of cervical cancer cases, while FHIT was not methylated in any of the 23 healthy NCs (Neyaz et al., 2008) . Another case-control study in China indicated that the rate of 5'CpG island methylation of the FHIT gene was 40.0% (16/40) in cervical cancer groups, while the rate of methylation in normal cervical tissue was 0% (0/10). The FHIT methylation rate in CIN1 (14.3%, 2/14) was statistically lower than its rate in CIN2 (56.3%, 13/23) (P<0.05) (Shi et al., 2005) .
The present study shows in the beginning that there was a significant interaction between HPV 16 infection and serum folate levels and FHIT methylation in cervical tissue. The factors for HPV 16 infection and FHIT methylation and folate deficiency existed at the same time or two of them existed have higher risks than that of one of them existed or all absent. It is generally known that HPV infection is the primary cause of SCC. Aberrant DNA methylation is associated with cervical pathogenesis (Flatley et al., 2012; Pathak et al., 2012) . The study demonstrated that women with a lower serum folate level and HPV 16 infection had a greater risk of SCC than those with a higher serum folate level and HPV negative, which was also revealed in a previous study (Piyathilake et al., 2007) .
The study also found that folate deficiency dramatically increased the risk of cervical cancer patients with high FHIT methylation for SCC. This could be due to low serum folate levels which lead to decreased DNA methyltransferase 1 (DNMT1) expression, which plays a significant role in maintaining DNA methylation status and regulating expression of tumor suppressor genes in cervical cancer cells . Chromosomal fragile site FRA3B at 3p14.2 located in the FHIT gene may be particularly prone to forming gaps or breaks on metaphase chromosomes under the conditions that inhibit DNA replication or repair, such as folate deficiency, which is an essential cofactor in de novo synthesis of purines and thymidylate-nucleotides necessary for DNA repair. The interaction between FHIT and HPV 16 would be caused by the fact that FRA3B fragile site of FHIT gene is a candidate region for HPV 16 interaction (Wilke et al., 1996) .
The study has several strengths. Firstly, it observed interactions between serum folate levels and HPV status and FHIT methylation rates for the first time. Second, serum and tissue samples originated from different stages of cervical cancer progression, including normal cervix, CIN and cervical cancer, which document natural cervical cancer progression. However, this study also has limitation. We only showed the relationships between folate and FHIT and HPV in cervical cancer progression, but did not indicate mechanisms of action even though other studies have indicated that folate may play an essential role in cervical lesions through impacting on DNA methylation (Flatley et al., 2009; Piyathilake et al., 2011) . Future studies should avoid these limitations.
